171 related articles for article (PubMed ID: 16889822)
1. Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix.
Yoshinaga K; Niikura H; Ogawa Y; Nemoto K; Nagase S; Takano T; Ito K; Yaegashi N
Gynecol Oncol; 2007 Jan; 104(1):36-40. PubMed ID: 16889822
[TBL] [Abstract][Full Text] [Related]
2. A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku Gynecologic Cancer Unit Study.
Yokoyama Y; Takano T; Nakahara K; Shoji T; Sato H; Yamada H; Yaegashi N; Okamura K; Kurachi H; Sugiyama T; Tanaka T; Sato A; Tase T; Mizunuma H
Oncol Rep; 2008 Jun; 19(6):1551-6. PubMed ID: 18497964
[TBL] [Abstract][Full Text] [Related]
3. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
Zhang MQ; Liu SP; Wang XE
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):821-7. PubMed ID: 20207507
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma.
Niioka T; Uno T; Yasui-Furukori N; Takahata T; Shimizu M; Sugawara K; Tateishi T
Cancer Chemother Pharmacol; 2007 Apr; 59(5):575-80. PubMed ID: 16912889
[TBL] [Abstract][Full Text] [Related]
5. [Concurrent chemoradiation therapy with nedaplatin for high-risk cervical cancer--clinical investigation of adverse events].
Kamiura S; Kobayashi K; Ohira H; Seino H; Hashimoto N; Sawai K; Samejima Y; Saji F
Gan To Kagaku Ryoho; 2001 Jul; 28(7):979-86. PubMed ID: 11478148
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma: Kitasato Gynecologic Radiation Oncology Group (KGROG 0501).
Niibe Y; Hayakawa K; Tsunoda S; Kanai T; Imai M; Arai M; Arai T; Kawaguchi M; Jobo T; Hamada Y; Yago K; Unno N;
Jpn J Clin Oncol; 2007 Jan; 37(1):70-2. PubMed ID: 17204507
[TBL] [Abstract][Full Text] [Related]
7. Maximum tolerated dose and early response - results of a phase I trial of paclitaxel and cisplatin with radiation therapy in carcinoma of the cervix.
Prasad E; Viswanathan PN; Rangad VF; Pavamani S; Ram TS
Clin Oncol (R Coll Radiol); 2009 Aug; 21(6):488-93. PubMed ID: 19386478
[TBL] [Abstract][Full Text] [Related]
8. A dose-finding and pharmacokinetic study of nedaplatin in elderly patients with advanced non-small cell lung cancer.
Yamamoto N; Tamura T; Kurata T; Yamamoto N; Sekine I; Kunitoh H; Ohe Y; Saijo N
Cancer Chemother Pharmacol; 2009 Dec; 65(1):79-88. PubMed ID: 19396598
[TBL] [Abstract][Full Text] [Related]
9. [A dose escalation study of concurrent chemoradiation therapy with nedaplatin for cervical cancer].
Hatae M; Takahashi T; Kodama S; Nakayama H; Kuzuya K; Saji F; Kamiura S; Watanabe Y; Nishimura R; Kono I; Ariyosh Y; Fukuoka M; Imajo Y; Hasegawa K; Noda K; ;
Gan To Kagaku Ryoho; 2005 Apr; 32(4):473-8. PubMed ID: 15853213
[TBL] [Abstract][Full Text] [Related]
10. [Phase II clinical trial of home-produced Nedaplatin in treating advanced esophageal carcinoma].
Xu RH; Shi YX; Guan ZZ; Jiang WQ; Huang H; Ma ZY; Wang JH; Hu XH; Xie WM; Li XG; Liu YL; Pan LX; Dai AD; Zhuang W; Zhang C
Ai Zheng; 2006 Dec; 25(12):1565-8. PubMed ID: 17166388
[TBL] [Abstract][Full Text] [Related]
11. [Concurrent weekly nedaplatin-based radiotherapy for high risk, recurrent and advanced cervical cancer].
Idei T; Sakamoto H; Nakajima Y; Hiraiwa Y; Takami N; Chishima F; Ohtani K; Nagaishi M; Yamamoto T; Kawamori J; Himi K; Tanaka Y
Gan To Kagaku Ryoho; 2003 Apr; 30(4):505-9. PubMed ID: 12722682
[TBL] [Abstract][Full Text] [Related]
12. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
[TBL] [Abstract][Full Text] [Related]
13. Results of a phase II trial of concurrent chemoradiation in the treatment of locally advanced carcinoma of uterine cervix: an experience from India.
Saibishkumar EP; Patel FD; Sharma SC
Bull Cancer; 2005 Jan; 92(1):E7-12. PubMed ID: 15811845
[TBL] [Abstract][Full Text] [Related]
14. Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: study of JROSG (Japan Radiation Oncology Study Group).
Sakata K; Sakurai H; Suzuki Y; Katoh S; Ohno T; Toita T; Kataoka M; Tanaka E; Kaneyasu Y; Uno T; Harima Y; Nakano T;
Acta Oncol; 2008; 47(3):434-41. PubMed ID: 18348003
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma (LAUCC): Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)--initial analysis.
Niibe Y; Tsunoda S; Jobo T; Imai M; Matsuo K; Matsunaga K; Unno N; Hayakawa K
Eur J Gynaecol Oncol; 2008; 29(3):222-4. PubMed ID: 18592783
[TBL] [Abstract][Full Text] [Related]
16. Phase I study of topotecan and radiation therapy in advanced cervical cancer.
Dunton CJ; King SA; Neufeld J; Tolosa J; Perez G; Avila A; Underhill K
Gynecol Oncol; 2002 Apr; 85(1):185-7. PubMed ID: 11925142
[TBL] [Abstract][Full Text] [Related]
17. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
Parker K; Gallop-Evans E; Hanna L; Adams M
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646
[TBL] [Abstract][Full Text] [Related]
18. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of satraplatin (JM216), an oral platinum (IV) complex under daily oral administration for 5 or 14 days.
Vouillamoz-Lorenz S; Buclin T; Lejeune F; Bauer J; Leyvraz S; Decosterd LA
Anticancer Res; 2003; 23(3C):2757-65. PubMed ID: 12926110
[TBL] [Abstract][Full Text] [Related]
20. Phase I study of chemoradiation with nedaplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix.
Kodama J; Takemoto M; Seki N; Nakamura K; Hongo A; Moriya S; Kanazawa S; Hiramatsu Y
Int J Gynecol Cancer; 2008; 18(6):1300-4. PubMed ID: 18284451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
